Cardiovascular Systems Inc. (NASDAQ:CSII) shares were up 2.1% during trading on Friday . The company traded as high as $19.32 and last traded at $19.29, with a volume of 309,342 shares traded. The stock had previously closed at $18.90.

A number of research analysts have commented on CSII shares. Zacks Investment Research cut Cardiovascular Systems from a “buy” rating to a “hold” rating in a research note on Tuesday, July 5th. Needham & Company LLC upgraded Cardiovascular Systems from an “underperform” rating to a “buy” rating and set a $16.00 price target on the stock in a research note on Friday, April 1st. Finally, Leerink Swann restated a “market perform” rating and set a $15.00 price target (up from $13.00) on shares of Cardiovascular Systems in a research note on Saturday, May 7th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $20.57.

The stock’s 50 day moving average is $18.06 and its 200 day moving average is $13.43. The company’s market cap is $632.22 million.

Cardiovascular Systems (NASDAQ:CSII) last issued its quarterly earnings data on Wednesday, May 4th. The medical device company reported ($0.31) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.54) by $0.23. During the same period last year, the business earned ($0.34) earnings per share. The business had revenue of $44.50 million for the quarter, compared to analysts’ expectations of $42.13 million. The company’s revenue for the quarter was down 5.3% on a year-over-year basis. On average, equities analysts anticipate that Cardiovascular Systems Inc. will post ($1.75) EPS for the current year.

A hedge fund recently raised its stake in Cardiovascular Systems stock. Brown Advisory Inc. raised its position in Cardiovascular Systems Inc. (NASDAQ:CSII) by 2.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 342,446 shares of the medical device company’s stock after buying an additional 7,010 shares during the period. Brown Advisory Inc. owned 1.05% of Cardiovascular Systems worth $5,178,000 at the end of the most recent quarter.

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.